BREAKING NEWS: Provo, Utah-based Canary Speech Closes $13 Million Round of Series A Funding to Help Advance its AI-based Early Detection of Mental and Emotional Health Challenges

As someone who watched the horrific progression of Alzheimer's Disease as it stripped away the mental and emotional essence of my mother over a six-year journey, I was pleased to see the announcement this morning that Canary Speech has landed a $13 million round of Series A funding.

Since its founding in 2016, the team at the Provo, Utah-based firm has been working on creating and bringing to market "... patented technology screens for mood, stress, and energy levels using a single 20-second audio clip."

As noted in today's funding announcement, Canary Speech utilizes

"... Ambient listening tools, which are systems designed to unobtrusively capture and analyze conversations in real-time, enable healthcare providers to focus on patient interactions while automatically documenting clinical notes."

The funding was led by Cortes Capital (Love's Private Equity), with participation from prior investors, including Utah-based Sorenson Communications, SMK (out of Japan), and Hackensack Meridian Health.

According to Crunchbase, with this funding round, Canary Speech has now raised $18.3 million across four rounds of funding.

Since mid-January 2022, Canary Speech has partnered with Irvine, California-based Syntiant to develop a "... new AI voice solution ... to detect Alzheimer’s Disease and other health conditions ... (via) digital biomarkers (that) enable voice analysis diagnosis in remote patient monitoring."

As noted in its graphic above, the Canary Speech API (application programming interface) utilizes patented vocal biomarker technologies to model acoustic and linguistic nuances to look for and identify early signs of mental and/or emotional health challenges, including

• Anxiety and stress,
• Depression and mood changes,
• Alzheimer's Disease,
• Parkinson's Disease,
• Huntington's Disease, and
• Other conditions,

each before such maladies are clinically observable.

Initial partners include

• Aspire 365,
• Galvan,
• NobleAI,
• OPPT Health,
• SMK, and
• Syntiant.

Good on ya, Team Canary Speech.

My family and I hope you find continued success.

PUBLISHER'S NOTE

In case you're not aware of Utah Money Watch, our goal is to publish Utah-focused monetary, financial, and/or business news, context, and analysis on a timely/regular basis, ideally information NOT available through any other source.

[You might think of us at the opposite of Bloomberg, CNBC, and/or The Wall Street Journal, each of which focus on international/national news first and rarely report on local happenings. Conversely, we are passionately focused on uncovering the most important monetary, financial, and/or business news and information that impact the organizations and people of Utah.]

Here again, the intent is to publish news, information, context, and analysis NOT available through any other source.

To that end, this article was originally published and distributed to our Subscribers at approximately 7:55am (MT) on Wednesday, 12 June 2024.

However, if you are seeing this report sometime after this date/time and you are interested in seeing similar reports and/or other Utah-focused monetary/financial/business news, context, and analysis write-ups in the future on an instantaneous basis when they are published, you can do so by subscribing, FOR FREE, to Utah Money Watch.

This will take less than 30 seconds and can be done from any page on the Utah Money Watch website.

Simply,

1. Click on a "Subscribe" button on any Utah Money Watch webpage,
2. Enter in your name in the proper field in the popup window that appears on-screen, and
3. Enter your preferred email address in the proper field too.

That's it. And "Yes," it really is that simple.

And ... it IS free.

So we hope to see you join us as a subscriber of Utah Money Watch.

Thanks.

Team Utah Money Watch